Literature DB >> 22740940

Overexpression of DJ-1 and HSP90α, and loss of PTEN associated with invasive urothelial carcinoma of urinary bladder: Possible prognostic markers.

Hojung Lee1, Seung Kyu Choi, Jae Y Ro.   

Abstract

DJ-1 and HSP90α play a significant role in the progression of various types of cancer and are known to be associated with phosphatase and tensin homolog deleted on chromosome 10 (PTEN), PI3K-p110α and pAkt, the signaling molecule proteins from the phosphatidylinositol 3-kinase (PI3K) pathway. However, the expression of these proteins and their clinical significance are not well characterized in urothelial carcinoma (UC). Immunohistochemical analysis of DJ-1, HSP90α, PTEN, pAkt and PI3K-p110α expression was performed on tumor samples from 102 patients with UC to assess the relationship between the expression of each protein and the pathological parameters. The expression of DJ-1 and HSP90α was positively correlated with the pathological stage of UC, whereas PTEN expression negatively correlated with, not only the pathological stage, but also the growth pattern and histological grade of UC. Although PI3K-p110α expression was significantly correlated with DJ-1 as well as PTEN expression in UC, PI3K-p110α expression itself failed to reveal any significant correlation with the clinicopathological parameters. In conclusion, the overexpression of DJ-1 and HSP90α, and a loss of PTEN are associated with invasive UC, and PI3K-p110α expression is correlated with DJ-1 and PTEN expression in UC.

Entities:  

Year:  2011        PMID: 22740940      PMCID: PMC3362422          DOI: 10.3892/ol.2011.522

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  40 in total

1.  DJ-1: a novel independent prognostic marker for survival in glottic squamous cell carcinoma.

Authors:  Xiao-Lin Zhu; Zhang-Feng Wang; Wen-Bin Lei; Hui-Wen Zhuang; Hong-Yan Jiang; Wei-Ping Wen
Journal:  Cancer Sci       Date:  2010-02-11       Impact factor: 6.716

Review 2.  HSP90 and the chaperoning of cancer.

Authors:  Luke Whitesell; Susan L Lindquist
Journal:  Nat Rev Cancer       Date:  2005-10       Impact factor: 60.716

3.  PIK3CA mutations are an early genetic alteration associated with FGFR3 mutations in superficial papillary bladder tumors.

Authors:  Elena López-Knowles; Silvia Hernández; Núria Malats; Manolis Kogevinas; Josep Lloreta; Alfredo Carrato; Adonina Tardón; Consol Serra; Francisco X Real
Journal:  Cancer Res       Date:  2006-08-01       Impact factor: 12.701

4.  DJ-1, a novel regulator of the tumor suppressor PTEN.

Authors:  Raymond H Kim; Malte Peters; YingJu Jang; Wei Shi; Melania Pintilie; Graham C Fletcher; Carmela DeLuca; Jennifer Liepa; Lily Zhou; Bryan Snow; Richard C Binari; Armen S Manoukian; Mark R Bray; Fei-Fei Liu; Ming-Sound Tsao; Tak W Mak
Journal:  Cancer Cell       Date:  2005-03       Impact factor: 31.743

5.  PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control.

Authors:  Maria-Magdalena Georgescu
Journal:  Genes Cancer       Date:  2010-12

6.  Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer.

Authors:  F Le Naour; D E Misek; M C Krause; L Deneux; T J Giordano; S Scholl; S M Hanash
Journal:  Clin Cancer Res       Date:  2001-11       Impact factor: 12.531

7.  Inactivation of p53 and Pten promotes invasive bladder cancer.

Authors:  Anna M Puzio-Kuter; Mireia Castillo-Martin; Carolyn W Kinkade; Xi Wang; Tian Huai Shen; Tulio Matos; Michael M Shen; Carlos Cordon-Cardo; Cory Abate-Shen
Journal:  Genes Dev       Date:  2009-03-04       Impact factor: 11.361

8.  Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer.

Authors:  David B Solit; S Percy Ivy; Catherine Kopil; Rachel Sikorski; Michael J Morris; Susan F Slovin; W Kevin Kelly; Anthony DeLaCruz; Tracy Curley; Glenn Heller; Steven Larson; Lawrence Schwartz; Merrill J Egorin; Neal Rosen; Howard I Scher
Journal:  Clin Cancer Res       Date:  2007-03-15       Impact factor: 12.531

9.  A phase I study of the heat shock protein 90 inhibitor alvespimycin (17-DMAG) given intravenously to patients with advanced solid tumors.

Authors:  Simon Pacey; Richard H Wilson; Mike Walton; Martin M Eatock; Anthea Hardcastle; Anna Zetterlund; Hendrik-Tobias Arkenau; Javier Moreno-Farre; Udai Banerji; Belle Roels; Heidi Peachey; Wynne Aherne; Johan S de Bono; Florence Raynaud; Paul Workman; Ian Judson
Journal:  Clin Cancer Res       Date:  2011-01-28       Impact factor: 12.531

Review 10.  Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer.

Authors:  Margaret A Knowles; Fiona M Platt; Rebecca L Ross; Carolyn D Hurst
Journal:  Cancer Metastasis Rev       Date:  2009-12       Impact factor: 9.264

View more
  22 in total

1.  The role of PTEN tumor suppressor pathway staining in carcinoma in situ of the bladder.

Authors:  John P Sfakianos; Lan Lin Gellert; Alexandra Maschino; Geoffrey T Gotto; Philip H Kim; Hikmat Al-Ahmadie; Bernard H Bochner
Journal:  Urol Oncol       Date:  2014-05-16       Impact factor: 3.498

2.  Differential expression of GSK3β and pS9GSK3β in normal human tissues: can pS9GSK3β be an epithelial marker?

Authors:  Hojung Lee; Jae Y Ro
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

3.  Microrna-136 promotes proliferation and invasion ingastric cancer cells through Pten/Akt/P-Akt signaling pathway.

Authors:  Xuyan Chen; Zhiming Huang; Renpin Chen
Journal:  Oncol Lett       Date:  2018-01-24       Impact factor: 2.967

4.  Gene microarray analysis of the lncRNA expression profile in human urothelial carcinoma of the bladder.

Authors:  Huarong Luo; Xin Zhao; Xiaodong Wan; Shengsong Huang; Denglong Wu
Journal:  Int J Clin Exp Med       Date:  2014-05-15

Review 5.  The role of heat shock proteins in bladder cancer.

Authors:  Joseph Ischia; Alan I So
Journal:  Nat Rev Urol       Date:  2013-05-14       Impact factor: 14.432

6.  High-expression of DJ-1 and loss of PTEN associated with tumor metastasis and correlated with poor prognosis of gastric carcinoma.

Authors:  Yin Li; Ji Cui; Chang-hua Zhang; Dong-jie Yang; Jian-Hui Chen; Wen-hua Zan; Bin Li; Zhi Li; Yu-long He
Journal:  Int J Med Sci       Date:  2013-09-24       Impact factor: 3.738

7.  Oxidant-induced Interprotein Disulfide Formation in Cardiac Protein DJ-1 Occurs via an Interaction with Peroxiredoxin 2.

Authors:  Mariana Fernandez-Caggiano; Ewald Schröder; Hyun-Ju Cho; Joseph Burgoyne; Javier Barallobre-Barreiro; Manuel Mayr; Philip Eaton
Journal:  J Biol Chem       Date:  2016-03-04       Impact factor: 5.157

8.  Upregulation of DJ-1 expression in melanoma regulates PTEN/AKT pathway for cell survival and migration.

Authors:  Yoon Jin Lee; Woo Il Kim; Tae Heum Park; Jin Ho Bae; Hae Seon Nam; Sung Woo Cho; Young Jin Choi; Sang Han Lee; Moon Kyun Cho
Journal:  Arch Dermatol Res       Date:  2020-09-21       Impact factor: 3.017

9.  Tumorigenesis role and clinical significance of DJ-1, a negative regulator of PTEN, in supraglottic squamous cell carcinoma.

Authors:  Xiao-Lin Zhu; Zhang-Feng Wang; Wen-Bin Lei; Hui-Wen Zhuang; Wei-Jian Hou; Yi-Hui Wen; Wei-Ping Wen
Journal:  J Exp Clin Cancer Res       Date:  2012-11-14

10.  Highly sensitive and specific novel biomarkers for the diagnosis of transitional bladder carcinoma.

Authors:  Prashant Kumar; Sayantani Nandi; Tuan Zea Tan; Siok Ghee Ler; Kee Seng Chia; Wei-Yen Lim; Zentia Bütow; Dimitrios Vordos; Alexandre De la Taille; Muthafar Al-Haddawi; Manfred Raida; Burkhard Beyer; Estelle Ricci; Marc Colombel; Tsung Wen Chong; Edmund Chiong; Ross Soo; Mi Kyoung Park; Hong Koo Ha; Jayantha Gunaratne; Jean Paul Thiery
Journal:  Oncotarget       Date:  2015-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.